Qiagen NV (QGEN)
42.28
-0.35
(-0.82%)
USD |
NYSE |
Nov 14, 12:33
Qiagen Gross Profit Margin (Quarterly): 7.00% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 7.00% |
| March 31, 2024 | 63.42% |
| December 31, 2023 | 62.08% |
| September 30, 2023 | 62.61% |
| June 30, 2023 | 63.08% |
| March 31, 2023 | 63.35% |
| December 31, 2022 | 63.76% |
| September 30, 2022 | 64.26% |
| June 30, 2022 | 64.21% |
| March 31, 2022 | 66.04% |
| December 31, 2021 | 64.19% |
| September 30, 2021 | 63.06% |
| June 30, 2021 | 65.08% |
| March 31, 2021 | 65.34% |
| December 31, 2020 | 65.37% |
| September 30, 2020 | 66.31% |
| June 30, 2020 | 66.55% |
| March 31, 2020 | 65.45% |
| December 31, 2019 | 67.61% |
| September 30, 2019 | 66.62% |
| June 30, 2019 | 64.44% |
| March 31, 2019 | 64.49% |
| December 31, 2018 | 65.67% |
| September 30, 2018 | 67.95% |
| June 30, 2018 | 67.27% |
| Date | Value |
|---|---|
| March 31, 2018 | 65.69% |
| December 31, 2017 | 65.84% |
| September 30, 2017 | 66.18% |
| June 30, 2017 | 64.34% |
| March 31, 2017 | 63.65% |
| December 31, 2016 | 62.21% |
| September 30, 2016 | 65.27% |
| June 30, 2016 | 63.04% |
| March 31, 2016 | 61.93% |
| December 31, 2015 | 64.15% |
| September 30, 2015 | 65.06% |
| June 30, 2015 | 62.78% |
| March 31, 2015 | 66.30% |
| December 31, 2014 | 59.94% |
| September 30, 2014 | 66.33% |
| June 30, 2014 | 65.25% |
| March 31, 2014 | 66.27% |
| December 31, 2013 | 65.32% |
| September 30, 2013 | 65.41% |
| June 30, 2013 | 53.59% |
| March 31, 2013 | 65.89% |
| December 31, 2012 | 67.10% |
| September 30, 2012 | 65.45% |
| June 30, 2012 | 66.07% |
| March 31, 2012 | 63.89% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
7.00%
Minimum
Jun 2024
67.61%
Maximum
Dec 2019
61.51%
Average
64.21%
Median
Jun 2022
Gross Profit Margin (Quarterly) Benchmarks
| LENZ Therapeutics Inc | -- |
| Oruka Therapeutics Inc | -- |
| Boston Scientific Corp | 68.83% |
| uniQure NV | 55.36% |
| ProQR Therapeutics NV | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.00% |
| Return on Assets | 1.22% |
| Return on Invested Capital | 1.40% |
| Profit Margin (Quarterly) | -36.96% |
| Operating Margin (Quarterly) | -32.31% |
| Return on Net Operating Assets | 1.63% |